Droplet Biosciences, Inc. — Form D
Droplet Biosciences, Inc. of Cambridge, MA, a company, filed a Form D exempt-offering notice with the SEC on 2023-12-13. The offering totals $14.1M, of which $7.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-12-13
- Form: D
- Accession: 0001847243-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $14.1M
- Amount sold: $7.6M
- Remaining: $6.5M
- Investors: 21
- Date of first sale: 2023-11-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-499503
Issuer
- Name: Droplet Biosciences, Inc.
- CIK: 0001847243
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 750 Main Street, Cambridge, MA, 02139
- Phone: (832) 622-8454
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Ann DeWitt | Director | Woburn, MA |
| Stanley Lapidus | Director | BOSTON, MA |
| Rachel Sha | Director | Woburn, MA |
| Theresa Tribble | Director | Cambridge, MA |
| Jose Zevallos | Director | Cambridge, MA |
| Theresa Tribble | Executive Officer | Cambridge, MA |
| Aadel Chaudhuri | Director | Chesterfield, MO |
| Aadel Chaudhuri | Executive Officer | Chesterfield, MO |
Other filings by this issuer (1)
More